Pfizer Inc. (NYSE:PFE)

The period under review demonstrates significant fluctuations in economic profit. Initial positive economic profit declined substantially, transitioning into negative values before stabilizing at a negative level. Net operating profit after taxes (NOPAT) exhibited a strong increase initially, followed by a substantial decline and subsequent modest recovery. Invested capital consistently increased over the period, although the rate of increase varied. The cost of capital remained relatively stable, with a slight increase in the initial years followed by a decrease and stabilization.

Economic Profit Trend

Economic profit began at US$10,093 million in 2021 and rose to US$20,322 million in 2022, indicating strong value creation. However, a dramatic shift occurred in 2023, with economic profit falling to a loss of US$14,227 million. This trend continued in 2024 with a loss of US$4,149 million, and remained negative in 2025 at US$4,726 million. The magnitude of the loss decreased slightly between 2024 and 2025, but remained substantial.

NOPAT Performance

NOPAT mirrored the initial positive trend in economic profit, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant decline followed in 2023, resulting in a loss of US$1,277 million. NOPAT recovered to US$7,374 million in 2024 and remained relatively stable at US$7,193 million in 2025. The 2023 loss in NOPAT appears to be a primary driver of the negative economic profit observed in subsequent years.

Invested Capital and Cost of Capital Relationship

Invested capital increased from US$87,670 million in 2021 to US$154,882 million in 2023, representing a substantial expansion of capital employed. While invested capital decreased to US$135,342 million in 2024, it increased again to US$139,753 million in 2025. The cost of capital remained relatively consistent, fluctuating between 8.36% and 9.66% throughout the period. The increasing invested capital, coupled with a relatively stable cost of capital, suggests that the decline in economic profit is primarily attributable to NOPAT performance rather than changes in the capital structure or cost of funding.

In summary, the period began with strong economic profit driven by increasing NOPAT. However, a substantial decline in NOPAT in 2023 led to negative economic profit, which persisted through 2025 despite a modest recovery in NOPAT. The increasing invested capital did not translate into increased economic profit, indicating a potential issue with capital allocation or operational efficiency.

Net income attributable to Pfizer Inc. common shareholders and Net Operating Profit After Taxes (NOPAT) exhibited significant fluctuations between 2021 and 2025. While net income demonstrated an initial increase followed by a substantial decline, NOPAT mirrored this pattern with even more pronounced volatility, including a negative value in 2023.

Net Income Trend

Net income attributable to Pfizer Inc. common shareholders increased from US$21,979 million in 2021 to US$31,372 million in 2022, representing a substantial year-over-year growth. However, a dramatic decrease was observed in 2023, falling to US$2,119 million. A partial recovery occurred in 2024, with net income reaching US$8,031 million, followed by a slight decrease to US$7,771 million in 2025.

NOPAT Trend

NOPAT followed a similar trajectory to net income, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant shift occurred in 2023, with NOPAT becoming negative at US$-1,277 million. A recovery was then seen in 2024, rising to US$7,374 million, and continuing to US$7,193 million in 2025. The magnitude of the decline and subsequent recovery in NOPAT was greater than that observed in net income.

Relationship between Net Income and NOPAT

While both metrics generally moved in the same direction, the divergence in 2023 is noteworthy. The substantial negative NOPAT value suggests that operating profits, after accounting for taxes, were insufficient to cover the cost of capital employed during that year, despite a positive, albeit significantly reduced, net income. This indicates that factors beyond core operational profitability, such as financing or non-operating items, played a larger role in determining net income in 2023.

The period between 2024 and 2025 shows relative stabilization in both metrics, although NOPAT remains considerably lower than its peak in 2022. Further investigation would be required to understand the underlying drivers of these fluctuations and their implications for the company’s long-term financial performance.

The provision for taxes on income exhibits significant volatility over the observed period. Beginning at US$1,852 million in 2021, it increased substantially to US$3,328 million in 2022 before experiencing a dramatic shift to a benefit of negative US$1,115 million in 2023. This benefit continued, albeit at a smaller magnitude, in 2024 (-US$28 million) and 2025 (-US$267 million). In contrast, cash operating taxes demonstrate a more stable, though fluctuating, pattern.

Cash Operating Taxes Trend

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a substantial rise. A subsequent decrease was noted in 2023, falling to US$2,113 million. Values then recovered somewhat in 2024 and 2025, reaching US$2,426 million and US$2,334 million respectively. While fluctuating, the values in 2024 and 2025 remain considerably below the 2021 and 2022 levels.

The divergence between the provision for taxes on income and cash operating taxes is noteworthy. The large benefit recorded in the provision for taxes in 2023, 2024, and 2025 suggests the utilization of tax loss carryforwards or other tax planning strategies, resulting in a reduced accounting expense despite continued cash outflows for taxes. The cash operating taxes, while decreasing from 2022 to 2023, remained positive throughout the period, indicating actual cash payments were made to tax authorities even when the accounting provision reflected a benefit.

Relationship between Provision and Cash Taxes

The difference between the provision for taxes on income and cash operating taxes widened considerably in 2023, 2024, and 2025. This indicates a growing deferral of taxable income or an increasing benefit from tax credits or loss carryforwards. The substantial difference highlights the impact of non-cash tax items on the reported income tax expense.

The observed trends suggest a complex tax position, potentially involving significant tax planning and the utilization of deferred tax assets. Further investigation into the specific drivers of the tax benefit and the nature of the deferred tax items would be beneficial for a complete understanding of the company’s tax strategy and its impact on financial performance.

The reported invested capital demonstrates a clear increasing trend over the observed period, followed by a stabilization and slight increase. A significant rise is noted between 2021 and 2023, while subsequent years show a more moderate pattern. This analysis details the observed movements in invested capital alongside its constituent components: total reported debt & leases and total shareholders’ equity.

Invested Capital Trend

Invested capital increased substantially from US$87,670 million in 2021 to US$154,882 million in 2023, representing a growth of approximately 76.8%. This growth slowed considerably in 2024, with invested capital decreasing to US$135,342 million. A modest increase to US$139,753 million was observed in 2025. The 2024 decrease suggests a potential shift in capital allocation strategy or a reduction in capital-intensive projects.

Debt & Leases

Total reported debt & leases decreased from US$41,395 million in 2021 to US$39,046 million in 2022. However, a substantial increase occurred in 2023, reaching US$75,041 million. This was followed by a decrease to US$66,993 million in 2024 and a slight increase to US$67,416 million in 2025. The 2023 surge in debt likely contributed significantly to the overall increase in invested capital during that year.

Shareholders’ Equity

Total shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022, indicating strong equity growth. A decrease was then observed in 2023, falling to US$89,014 million, and continued to decline in 2024 and 2025, reaching US$88,203 million and US$86,476 million respectively. This consistent decline in shareholders’ equity over the latter part of the period partially offset the impact of increased debt on invested capital.

The interplay between debt and equity significantly influences the overall invested capital. While debt increased substantially in 2023, the subsequent decrease in shareholders’ equity moderated the growth in invested capital in 2024 and 2025. The stabilization of invested capital in the later years suggests a balancing act between debt financing and equity returns.

The economic spread ratio exhibited a fluctuating pattern over the five-year period. Initially, the ratio demonstrated substantial growth, followed by a significant decline into negative territory. Economic profit experienced a similar trajectory, initially increasing and then becoming negative.

Economic Spread Ratio

The economic spread ratio began at 11.51% in 2021 and increased to 18.35% in 2022, indicating an improved ability to generate returns exceeding the cost of capital. However, a sharp reversal occurred in 2023, with the ratio plummeting to -9.19%. This negative trend continued in subsequent years, reaching -3.07% in 2024 and -3.38% in 2025. The consistent negative values in the latter years suggest that invested capital is generating returns below the company’s cost of capital.

Invested capital consistently increased from 2021 to 2023, rising from US$87,670 million to US$154,882 million. While invested capital decreased slightly in 2024 to US$135,342 million, it experienced a modest increase in 2025 to US$139,753 million. The increase in invested capital did not translate into corresponding increases in economic profit, as evidenced by the declining economic spread ratio.

Economic Profit and Invested Capital Relationship

The divergence between invested capital and economic profit is notable. While invested capital grew significantly between 2021 and 2023, economic profit turned negative in 2023 and remained so through 2025. This suggests that the company’s investments are not yielding sufficient returns to cover the cost of capital. The negative economic profit values directly contribute to the negative economic spread ratio observed in the later years.

The shift from positive to negative economic spread ratios, coupled with the increasing invested capital, warrants further investigation into the efficiency of capital allocation and the underlying drivers of profitability. The sustained negative economic spread ratio indicates a potential erosion of shareholder value.

The economic profit margin exhibited significant fluctuations over the five-year period. Initially positive, it transitioned to negative values, indicating a decline in economic profitability. A detailed examination of the trends reveals a notable shift in the company’s ability to generate returns exceeding its cost of capital.

Economic Profit Margin Trend

In 2021, the economic profit margin stood at 12.29%. This value more than doubled in 2022, reaching 20.09%, suggesting a substantial improvement in profitability relative to the capital employed. However, a dramatic reversal occurred in 2023, with the margin plummeting to -23.89%. This indicates that the company’s economic profit became significantly negative, meaning returns fell short of the cost of capital. The margin remained negative in 2024 and 2025, at -6.52% and -7.55% respectively, although the magnitude of the loss lessened slightly.

Relationship to Revenues

Revenues increased from US$82,145 million in 2021 to US$101,175 million in 2022, coinciding with the peak in the economic profit margin. However, revenues decreased substantially to US$59,553 million in 2023, aligning with the sharp decline in the economic profit margin. While revenues experienced modest growth in 2024 and 2025, reaching US$63,627 million and US$62,579 million respectively, these increases were insufficient to restore the economic profit margin to positive territory.

Economic Profit Trend

The absolute economic profit followed a similar pattern to the margin. It rose from US$10,093 million in 2021 to US$20,322 million in 2022. The subsequent years saw substantial declines, with economic profit becoming negative in 2023 at -US$14,227 million, and remaining negative in 2024 (-US$4,149 million) and 2025 (-US$4,726 million). This indicates a consistent erosion of value creation over the latter part of the period.

The observed trends suggest a weakening relationship between revenue generation and economic profitability. While revenue growth initially supported improved economic performance, subsequent revenue declines and persistent negative economic profit margins indicate potential issues with cost management, capital efficiency, or competitive pressures.